Global Plasmid CDMO Services Market Growth (Status and Outlook) 2022-2028

Publication Month: Dec 2022 | No. of Pages: 110 Published By: LP Information
Single User License: US $ 3660
Corporate User License: US $ 7320

The global market for Plasmid CDMO Services is estimated to increase from US$ million in 2021 to reach US$ million by 2028, exhibiting a CAGR of % during 2022-2028. Keeping in mind the uncertainties of COVID-19 and Russia-Ukraine War, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
The APAC Plasmid CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The United States Plasmid CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The Europe Plasmid CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
The China Plasmid CDMO Services market is expected at value of US$ million in 2022 and grow at approximately % CAGR during 2022 and 2028.
Global key Plasmid CDMO Services players cover GenScript ProBio, PackGene Biotech, Hillgene, Porton Advanced Solutions and Catalent, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
Report Coverage
This latest report provides a deep insight into the global Plasmid CDMO Services market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, value chain analysis, etc.
This report aims to provide a comprehensive picture of the global Plasmid CDMO Services market, with both quantitative and qualitative data, to help readers understand how the Plasmid CDMO Services market scenario changed across the globe during the pandemic and Russia-Ukraine War.
The base year considered for analyses is 2021, while the market estimates and forecasts are given from 2022 to 2028. The market estimates are provided in terms of revenue in USD millions.
Market Segmentation:
The study segments the Plasmid CDMO Services market and forecasts the market size by Type (IIT Grade, IND Grade and Clinical Trial Grade), by Application (Biopharmaceutical Company and Academic Scientific Research Institution.), and region (APAC, Americas, Europe, and Middle East & Africa).
Segmentation by type
IIT Grade
IND Grade
Clinical Trial Grade
Commercial Production Grade
Segmentation by application
Biopharmaceutical Company
Academic Scientific Research Institution
Segmentation by region
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
Major companies covered
GenScript ProBio
PackGene Biotech
Hillgene
Porton Advanced Solutions
Catalent
VectorBuilder
Ubrigene
Charles River Laboratories
Obio Technology (Shanghai)
Wacker Biotech US
Biovian
Curia
Lotuslake Biomedical
VGXI
Andelyn Biosciences
Esco Aster
BioCina
Merck
Chapter Introduction
Chapter 1: Scope of Plasmid CDMO Services, Research Methodology, etc.
Chapter 2: Executive Summary, global Plasmid CDMO Services market size and CAGR, Plasmid CDMO Services market size by region, by type, by application, historical data from 2017 to 2022, and forecast to 2028.
Chapter 3: Plasmid CDMO Services revenue, global market share, and industry ranking by company, 2017-2022
Chapter 4: Global Plasmid CDMO Services revenue by region and by country. Country specific data and market value analysis for the U.S., Canada, Europe, China, Japan, South Korea, Southeast Asia, India, Latin America and Middle East & Africa.
Chapter 5, 6, 7, 8: Americas, APAC, Europe, Middle East & Africa, revenue segment by country, by type, and application.
Chapter 9: Analysis of the current market trends, market forecast, opportunities and economic trends that are affecting the future marketplace
Chapter 10: Manufacturing cost structure analysis
Chapter 11: Sales channel, distributors, and customers
Chapter 12: Global Plasmid CDMO Services market size forecast by region, by country, by type, and application
Chapter 13: Comprehensive company profiles of the leading players, including GenScript ProBio, PackGene Biotech, Hillgene, Porton Advanced Solutions, Catalent, VectorBuilder, Ubrigene, Charles River Laboratories and Obio Technology (Shanghai), etc.
Chapter 14: Research Findings and Conclusion

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Plasmid CDMO Services Market Size 2017-2028
2.1.2 Plasmid CDMO Services Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Plasmid CDMO Services Segment by Type
2.2.1 IIT Grade
2.2.2 IND Grade
2.2.3 Clinical Trial Grade
2.2.4 Commercial Production Grade
2.3 Plasmid CDMO Services Market Size by Type
2.3.1 Plasmid CDMO Services Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Plasmid CDMO Services Market Size Market Share by Type (2017-2022)
2.4 Plasmid CDMO Services Segment by Application
2.4.1 Biopharmaceutical Company
2.4.2 Academic Scientific Research Institution
2.5 Plasmid CDMO Services Market Size by Application
2.5.1 Plasmid CDMO Services Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Plasmid CDMO Services Market Size Market Share by Application (2017-2022)
3 Plasmid CDMO Services Market Size by Player
3.1 Plasmid CDMO Services Market Size Market Share by Players
3.1.1 Global Plasmid CDMO Services Revenue by Players (2020-2022)
3.1.2 Global Plasmid CDMO Services Revenue Market Share by Players (2020-2022)
3.2 Global Plasmid CDMO Services Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Plasmid CDMO Services by Regions
4.1 Plasmid CDMO Services Market Size by Regions (2017-2022)
4.2 Americas Plasmid CDMO Services Market Size Growth (2017-2022)
4.3 APAC Plasmid CDMO Services Market Size Growth (2017-2022)
4.4 Europe Plasmid CDMO Services Market Size Growth (2017-2022)
4.5 Middle East & Africa Plasmid CDMO Services Market Size Growth (2017-2022)
5 Americas
5.1 Americas Plasmid CDMO Services Market Size by Country (2017-2022)
5.2 Americas Plasmid CDMO Services Market Size by Type (2017-2022)
5.3 Americas Plasmid CDMO Services Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Plasmid CDMO Services Market Size by Region (2017-2022)
6.2 APAC Plasmid CDMO Services Market Size by Type (2017-2022)
6.3 APAC Plasmid CDMO Services Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Plasmid CDMO Services by Country (2017-2022)
7.2 Europe Plasmid CDMO Services Market Size by Type (2017-2022)
7.3 Europe Plasmid CDMO Services Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Plasmid CDMO Services by Region (2017-2022)
8.2 Middle East & Africa Plasmid CDMO Services Market Size by Type (2017-2022)
8.3 Middle East & Africa Plasmid CDMO Services Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Plasmid CDMO Services Market Forecast
10.1 Global Plasmid CDMO Services Forecast by Regions (2023-2028)
10.1.1 Global Plasmid CDMO Services Forecast by Regions (2023-2028)
10.1.2 Americas Plasmid CDMO Services Forecast
10.1.3 APAC Plasmid CDMO Services Forecast
10.1.4 Europe Plasmid CDMO Services Forecast
10.1.5 Middle East & Africa Plasmid CDMO Services Forecast
10.2 Americas Plasmid CDMO Services Forecast by Country (2023-2028)
10.2.1 United States Plasmid CDMO Services Market Forecast
10.2.2 Canada Plasmid CDMO Services Market Forecast
10.2.3 Mexico Plasmid CDMO Services Market Forecast
10.2.4 Brazil Plasmid CDMO Services Market Forecast
10.3 APAC Plasmid CDMO Services Forecast by Region (2023-2028)
10.3.1 China Plasmid CDMO Services Market Forecast
10.3.2 Japan Plasmid CDMO Services Market Forecast
10.3.3 Korea Plasmid CDMO Services Market Forecast
10.3.4 Southeast Asia Plasmid CDMO Services Market Forecast
10.3.5 India Plasmid CDMO Services Market Forecast
10.3.6 Australia Plasmid CDMO Services Market Forecast
10.4 Europe Plasmid CDMO Services Forecast by Country (2023-2028)
10.4.1 Germany Plasmid CDMO Services Market Forecast
10.4.2 France Plasmid CDMO Services Market Forecast
10.4.3 UK Plasmid CDMO Services Market Forecast
10.4.4 Italy Plasmid CDMO Services Market Forecast
10.4.5 Russia Plasmid CDMO Services Market Forecast
10.5 Middle East & Africa Plasmid CDMO Services Forecast by Region (2023-2028)
10.5.1 Egypt Plasmid CDMO Services Market Forecast
10.5.2 South Africa Plasmid CDMO Services Market Forecast
10.5.3 Israel Plasmid CDMO Services Market Forecast
10.5.4 Turkey Plasmid CDMO Services Market Forecast
10.5.5 GCC Countries Plasmid CDMO Services Market Forecast
10.6 Global Plasmid CDMO Services Forecast by Type (2023-2028)
10.7 Global Plasmid CDMO Services Forecast by Application (2023-2028)

11 Key Players Analysis
11.1 GenScript ProBio
11.1.1 GenScript ProBio Company Information
11.1.2 GenScript ProBio Plasmid CDMO Services Product Offered
11.1.3 GenScript ProBio Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 GenScript ProBio Main Business Overview
11.1.5 GenScript ProBio Latest Developments
11.2 PackGene Biotech
11.2.1 PackGene Biotech Company Information
11.2.2 PackGene Biotech Plasmid CDMO Services Product Offered
11.2.3 PackGene Biotech Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 PackGene Biotech Main Business Overview
11.2.5 PackGene Biotech Latest Developments
11.3 Hillgene
11.3.1 Hillgene Company Information
11.3.2 Hillgene Plasmid CDMO Services Product Offered
11.3.3 Hillgene Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Hillgene Main Business Overview
11.3.5 Hillgene Latest Developments
11.4 Porton Advanced Solutions
11.4.1 Porton Advanced Solutions Company Information
11.4.2 Porton Advanced Solutions Plasmid CDMO Services Product Offered
11.4.3 Porton Advanced Solutions Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Porton Advanced Solutions Main Business Overview
11.4.5 Porton Advanced Solutions Latest Developments
11.5 Catalent
11.5.1 Catalent Company Information
11.5.2 Catalent Plasmid CDMO Services Product Offered
11.5.3 Catalent Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Catalent Main Business Overview
11.5.5 Catalent Latest Developments
11.6 VectorBuilder
11.6.1 VectorBuilder Company Information
11.6.2 VectorBuilder Plasmid CDMO Services Product Offered
11.6.3 VectorBuilder Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 VectorBuilder Main Business Overview
11.6.5 VectorBuilder Latest Developments
11.7 Ubrigene
11.7.1 Ubrigene Company Information
11.7.2 Ubrigene Plasmid CDMO Services Product Offered
11.7.3 Ubrigene Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Ubrigene Main Business Overview
11.7.5 Ubrigene Latest Developments
11.8 Charles River Laboratories
11.8.1 Charles River Laboratories Company Information
11.8.2 Charles River Laboratories Plasmid CDMO Services Product Offered
11.8.3 Charles River Laboratories Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Charles River Laboratories Main Business Overview
11.8.5 Charles River Laboratories Latest Developments
11.9 Obio Technology (Shanghai)
11.9.1 Obio Technology (Shanghai) Company Information
11.9.2 Obio Technology (Shanghai) Plasmid CDMO Services Product Offered
11.9.3 Obio Technology (Shanghai) Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Obio Technology (Shanghai) Main Business Overview
11.9.5 Obio Technology (Shanghai) Latest Developments
11.10 Wacker Biotech US
11.10.1 Wacker Biotech US Company Information
11.10.2 Wacker Biotech US Plasmid CDMO Services Product Offered
11.10.3 Wacker Biotech US Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Wacker Biotech US Main Business Overview
11.10.5 Wacker Biotech US Latest Developments
11.11 Biovian
11.11.1 Biovian Company Information
11.11.2 Biovian Plasmid CDMO Services Product Offered
11.11.3 Biovian Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Biovian Main Business Overview
11.11.5 Biovian Latest Developments
11.12 Curia
11.12.1 Curia Company Information
11.12.2 Curia Plasmid CDMO Services Product Offered
11.12.3 Curia Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Curia Main Business Overview
11.12.5 Curia Latest Developments
11.13 Lotuslake Biomedical
11.13.1 Lotuslake Biomedical Company Information
11.13.2 Lotuslake Biomedical Plasmid CDMO Services Product Offered
11.13.3 Lotuslake Biomedical Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Lotuslake Biomedical Main Business Overview
11.13.5 Lotuslake Biomedical Latest Developments
11.14 VGXI
11.14.1 VGXI Company Information
11.14.2 VGXI Plasmid CDMO Services Product Offered
11.14.3 VGXI Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 VGXI Main Business Overview
11.14.5 VGXI Latest Developments
11.15 Andelyn Biosciences
11.15.1 Andelyn Biosciences Company Information
11.15.2 Andelyn Biosciences Plasmid CDMO Services Product Offered
11.15.3 Andelyn Biosciences Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Andelyn Biosciences Main Business Overview
11.15.5 Andelyn Biosciences Latest Developments
11.16 Esco Aster
11.16.1 Esco Aster Company Information
11.16.2 Esco Aster Plasmid CDMO Services Product Offered
11.16.3 Esco Aster Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Esco Aster Main Business Overview
11.16.5 Esco Aster Latest Developments
11.17 BioCina
11.17.1 BioCina Company Information
11.17.2 BioCina Plasmid CDMO Services Product Offered
11.17.3 BioCina Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 BioCina Main Business Overview
11.17.5 BioCina Latest Developments
11.18 Merck
11.18.1 Merck Company Information
11.18.2 Merck Plasmid CDMO Services Product Offered
11.18.3 Merck Plasmid CDMO Services Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Merck Main Business Overview
11.18.5 Merck Latest Developments
12 Research Findings and Conclusion

Tables and Figures

List of Tables
Table 1. Plasmid CDMO Services Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of IIT Grade
Table 3. Major Players of IND Grade
Table 4. Major Players of Clinical Trial Grade
Table 5. Major Players of Commercial Production Grade
Table 6. Plasmid CDMO Services Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 7. Global Plasmid CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 8. Global Plasmid CDMO Services Market Size Market Share by Type (2017-2022)
Table 9. Plasmid CDMO Services Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Plasmid CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 11. Global Plasmid CDMO Services Market Size Market Share by Application (2017-2022)
Table 12. Global Plasmid CDMO Services Revenue by Players (2020-2022) & ($ Millions)
Table 13. Global Plasmid CDMO Services Revenue Market Share by Player (2020-2022)
Table 14. Plasmid CDMO Services Key Players Head office and Products Offered
Table 15. Plasmid CDMO Services Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Plasmid CDMO Services Market Size by Regions 2017-2022 & ($ Millions)
Table 19. Global Plasmid CDMO Services Market Size Market Share by Regions (2017-2022)
Table 20. Americas Plasmid CDMO Services Market Size by Country (2017-2022) & ($ Millions)
Table 21. Americas Plasmid CDMO Services Market Size Market Share by Country (2017-2022)
Table 22. Americas Plasmid CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 23. Americas Plasmid CDMO Services Market Size Market Share by Type (2017-2022)
Table 24. Americas Plasmid CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 25. Americas Plasmid CDMO Services Market Size Market Share by Application (2017-2022)
Table 26. APAC Plasmid CDMO Services Market Size by Region (2017-2022) & ($ Millions)
Table 27. APAC Plasmid CDMO Services Market Size Market Share by Region (2017-2022)
Table 28. APAC Plasmid CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 29. APAC Plasmid CDMO Services Market Size Market Share by Type (2017-2022)
Table 30. APAC Plasmid CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 31. APAC Plasmid CDMO Services Market Size Market Share by Application (2017-2022)
Table 32. Europe Plasmid CDMO Services Market Size by Country (2017-2022) & ($ Millions)
Table 33. Europe Plasmid CDMO Services Market Size Market Share by Country (2017-2022)
Table 34. Europe Plasmid CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 35. Europe Plasmid CDMO Services Market Size Market Share by Type (2017-2022)
Table 36. Europe Plasmid CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 37. Europe Plasmid CDMO Services Market Size Market Share by Application (2017-2022)
Table 38. Middle East & Africa Plasmid CDMO Services Market Size by Region (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Plasmid CDMO Services Market Size Market Share by Region (2017-2022)
Table 40. Middle East & Africa Plasmid CDMO Services Market Size by Type (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Plasmid CDMO Services Market Size Market Share by Type (2017-2022)
Table 42. Middle East & Africa Plasmid CDMO Services Market Size by Application (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Plasmid CDMO Services Market Size Market Share by Application (2017-2022)
Table 44. Key Market Drivers & Growth Opportunities of Plasmid CDMO Services
Table 45. Key Market Challenges & Risks of Plasmid CDMO Services
Table 46. Key Industry Trends of Plasmid CDMO Services
Table 47. Global Plasmid CDMO Services Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 48. Global Plasmid CDMO Services Market Size Market Share Forecast by Regions (2023-2028)
Table 49. Global Plasmid CDMO Services Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 50. Global Plasmid CDMO Services Market Size Market Share Forecast by Type (2023-2028)
Table 51. Global Plasmid CDMO Services Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 52. Global Plasmid CDMO Services Market Size Market Share Forecast by Application (2023-2028)
Table 53. GenScript ProBio Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 54. GenScript ProBio Plasmid CDMO Services Product Offered
Table 55. GenScript ProBio Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 56. GenScript ProBio Main Business
Table 57. GenScript ProBio Latest Developments
Table 58. PackGene Biotech Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 59. PackGene Biotech Plasmid CDMO Services Product Offered
Table 60. PackGene Biotech Main Business
Table 61. PackGene Biotech Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 62. PackGene Biotech Latest Developments
Table 63. Hillgene Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 64. Hillgene Plasmid CDMO Services Product Offered
Table 65. Hillgene Main Business
Table 66. Hillgene Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 67. Hillgene Latest Developments
Table 68. Porton Advanced Solutions Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 69. Porton Advanced Solutions Plasmid CDMO Services Product Offered
Table 70. Porton Advanced Solutions Main Business
Table 71. Porton Advanced Solutions Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 72. Porton Advanced Solutions Latest Developments
Table 73. Catalent Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 74. Catalent Plasmid CDMO Services Product Offered
Table 75. Catalent Main Business
Table 76. Catalent Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 77. Catalent Latest Developments
Table 78. VectorBuilder Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 79. VectorBuilder Plasmid CDMO Services Product Offered
Table 80. VectorBuilder Main Business
Table 81. VectorBuilder Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 82. VectorBuilder Latest Developments
Table 83. Ubrigene Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 84. Ubrigene Plasmid CDMO Services Product Offered
Table 85. Ubrigene Main Business
Table 86. Ubrigene Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 87. Ubrigene Latest Developments
Table 88. Charles River Laboratories Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 89. Charles River Laboratories Plasmid CDMO Services Product Offered
Table 90. Charles River Laboratories Main Business
Table 91. Charles River Laboratories Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 92. Charles River Laboratories Latest Developments
Table 93. Obio Technology (Shanghai) Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 94. Obio Technology (Shanghai) Plasmid CDMO Services Product Offered
Table 95. Obio Technology (Shanghai) Main Business
Table 96. Obio Technology (Shanghai) Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 97. Obio Technology (Shanghai) Latest Developments
Table 98. Wacker Biotech US Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 99. Wacker Biotech US Plasmid CDMO Services Product Offered
Table 100. Wacker Biotech US Main Business
Table 101. Wacker Biotech US Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 102. Wacker Biotech US Latest Developments
Table 103. Biovian Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 104. Biovian Plasmid CDMO Services Product Offered
Table 105. Biovian Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Biovian Main Business
Table 107. Biovian Latest Developments
Table 108. Curia Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 109. Curia Plasmid CDMO Services Product Offered
Table 110. Curia Main Business
Table 111. Curia Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 112. Curia Latest Developments
Table 113. Lotuslake Biomedical Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 114. Lotuslake Biomedical Plasmid CDMO Services Product Offered
Table 115. Lotuslake Biomedical Main Business
Table 116. Lotuslake Biomedical Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 117. Lotuslake Biomedical Latest Developments
Table 118. VGXI Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 119. VGXI Plasmid CDMO Services Product Offered
Table 120. VGXI Main Business
Table 121. VGXI Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 122. VGXI Latest Developments
Table 123. Andelyn Biosciences Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 124. Andelyn Biosciences Plasmid CDMO Services Product Offered
Table 125. Andelyn Biosciences Main Business
Table 126. Andelyn Biosciences Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 127. Andelyn Biosciences Latest Developments
Table 128. Esco Aster Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 129. Esco Aster Plasmid CDMO Services Product Offered
Table 130. Esco Aster Main Business
Table 131. Esco Aster Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 132. Esco Aster Latest Developments
Table 133. BioCina Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 134. BioCina Plasmid CDMO Services Product Offered
Table 135. BioCina Main Business
Table 136. BioCina Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 137. BioCina Latest Developments
Table 138. Merck Details, Company Type, Plasmid CDMO Services Area Served and Its Competitors
Table 139. Merck Plasmid CDMO Services Product Offered
Table 140. Merck Main Business
Table 141. Merck Plasmid CDMO Services Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 142. Merck Latest Developments
List of Figures
List of Figures
Figure 1. Plasmid CDMO Services Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Plasmid CDMO Services Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Plasmid CDMO Services Market Size Market Share by Type in 2021
Figure 7. Plasmid CDMO Services in Biopharmaceutical Company
Figure 8. Global Plasmid CDMO Services Market: Biopharmaceutical Company (2017-2022) & ($ Millions)
Figure 9. Plasmid CDMO Services in Academic Scientific Research Institution
Figure 10. Global Plasmid CDMO Services Market: Academic Scientific Research Institution (2017-2022) & ($ Millions)
Figure 11. Global Plasmid CDMO Services Market Size Market Share by Application in 2021
Figure 12. Global Plasmid CDMO Services Revenue Market Share by Player in 2021
Figure 13. Global Plasmid CDMO Services Market Size Market Share by Regions (2017-2022)
Figure 14. Americas Plasmid CDMO Services Market Size 2017-2022 ($ Millions)
Figure 15. APAC Plasmid CDMO Services Market Size 2017-2022 ($ Millions)
Figure 16. Europe Plasmid CDMO Services Market Size 2017-2022 ($ Millions)
Figure 17. Middle East & Africa Plasmid CDMO Services Market Size 2017-2022 ($ Millions)
Figure 18. Americas Plasmid CDMO Services Value Market Share by Country in 2021
Figure 19. Americas Plasmid CDMO Services Consumption Market Share by Type in 2021
Figure 20. Americas Plasmid CDMO Services Market Size Market Share by Application in 2021
Figure 21. United States Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 22. Canada Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 23. Mexico Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 24. Brazil Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 25. APAC Plasmid CDMO Services Market Size Market Share by Region in 2021
Figure 26. APAC Plasmid CDMO Services Market Size Market Share by Application in 2021
Figure 27. China Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 28. Japan Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 29. Korea Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 30. Southeast Asia Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 31. India Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 32. Australia Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 33. Europe Plasmid CDMO Services Market Size Market Share by Country in 2021
Figure 34. Europe Plasmid CDMO Services Market Size Market Share by Type in 2021
Figure 35. Europe Plasmid CDMO Services Market Size Market Share by Application in 2021
Figure 36. Germany Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 37. France Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 38. UK Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 39. Italy Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 40. Russia Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 41. Middle East & Africa Plasmid CDMO Services Market Size Market Share by Region in 2021
Figure 42. Middle East & Africa Plasmid CDMO Services Market Size Market Share by Type in 2021
Figure 43. Middle East & Africa Plasmid CDMO Services Market Size Market Share by Application in 2021
Figure 44. Egypt Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 45. South Africa Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 46. Israel Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 47. Turkey Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 48. GCC Country Plasmid CDMO Services Market Size Growth 2017-2022 ($ Millions)
Figure 49. Americas Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 50. APAC Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 51. Europe Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 52. Middle East & Africa Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 53. United States Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 54. Canada Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 55. Mexico Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 56. Brazil Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 57. China Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 58. Japan Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 59. Korea Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 60. Southeast Asia Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 61. India Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 62. Australia Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 63. Germany Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 64. France Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 65. UK Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 66. Italy Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 67. Russia Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 68. Spain Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 69. Egypt Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 70. South Africa Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 71. Israel Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 72. Turkey Plasmid CDMO Services Market Size 2023-2028 ($ Millions)
Figure 73. GCC Countries Plasmid CDMO Services Market Size 2023-2028 ($ Millions)


Reason to Buy

  • Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Medical Devices & Consumables Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets